Skip to content
10-Q

Quarterly Report

Transcode Therapeutics, Inc. RNAZ

0001829635-25-000004

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 916.97K sh
Shares Diluted Q3 2025 · Sep 30, 2025 833.68K sh
Shares Diluted Q3 2025 · Sep 30, 2025 615.26K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 15.89K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 9.7K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$11.37M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$10.19M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $2.84M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $5.81M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.43M
Stockholders Equity Q3 2025 · Jun 30, 2025 $6.15M
Stockholders Equity Q3 2025 · Mar 31, 2025 $10.29M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$2.02M
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.65M
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.32M
Stockholders Equity Q3 2025 · Mar 31, 2024 $4.58M
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.64M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.97M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.77M
Total Liabilities Q3 2025 · Sep 30, 2025 $3.8M
Total Liabilities Q3 2025 · Dec 31, 2024 $9.31M
Current Assets Q3 2025 · Sep 30, 2025 $4.75M
Current Assets Q3 2025 · Dec 31, 2024 $7.09M
Total Assets Q3 2025 · Sep 30, 2025 $5.23M
Total Assets Q3 2025 · Dec 31, 2024 $7.29M
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.82
Eps Diluted Q3 2025 · Sep 30, 2025 −$34.49
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$146.06
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$1,117.89
Eps Basic Q3 2025 · Sep 30, 2025 −$5.82
Eps Basic Q3 2025 · Sep 30, 2025 −$34.49
Eps Basic restated Q3 2025 · Sep 30, 2024 −$146.06
Eps Basic restated Q3 2025 · Sep 30, 2024 −$1,117.89
Sga Expense Q3 2025 · Sep 30, 2025 $1.4M
Sga Expense Q3 2025 · Sep 30, 2025 $4.01M
Sga Expense Q3 2025 · Sep 30, 2024 $938.03K
Sga Expense Q3 2025 · Sep 30, 2024 $4.5M
Rd Expense Q3 2025 · Sep 30, 2025 $3.16M
Rd Expense Q3 2025 · Sep 30, 2025 $7.95M
Rd Expense Q3 2025 · Sep 30, 2024 $1.23M
Rd Expense Q3 2025 · Sep 30, 2024 $6.07M
Net Income Q3 2025 · Sep 30, 2025 −$4.86M
Net Income Q3 2025 · Sep 30, 2025 −$21.22M
Net Income Q3 2025 · Jun 30, 2025 −$4.28M
Net Income Q3 2025 · Mar 31, 2025 −$12.09M
Net Income Q3 2025 · Sep 30, 2024 −$2.32M
Net Income Q3 2025 · Sep 30, 2024 −$10.84M
Net Income Q3 2025 · Jun 30, 2024 −$5.19M
Net Income Q3 2025 · Mar 31, 2024 −$3.33M
Operating Income Q3 2025 · Sep 30, 2025 −$4.56M
Operating Income Q3 2025 · Sep 30, 2025 −$11.95M
Operating Income Q3 2025 · Sep 30, 2024 −$2.17M
Operating Income Q3 2025 · Sep 30, 2024 −$10.57M
Capex Q3 2025 · Sep 30, 2024 $21.26K